APVO
Aptevo Therapeutics Inc.
$4.89
+3.60%
$6.1M
No data for this timeframe.
Vol
Market Cap$6.1M
Cap SizeNano Cap
Inst. Holders3 funds
Inst. Value$159.1K
Inst. Activity1 buys / 0 sells
SEC Reports2
Recent Activity
May 12, 2026
earnings_calendar
APVO Q1 2026 Earnings Scheduled — 2026-05-12
May 6, 2026
SEC
Aptevo announced positive clinical data from its RAINIER frontline AML trial, showing an 81% remission rate (CR/CRi) and
8-K — Impact 6/10
Mar 11, 2026
SEC
Aptevo Therapeutics announced positive interim clinical data for its drug candidate mipletamig in combination with venet
8-K — Impact 8/10
Inst.
VANGUARD GROUP INC — NEW
16,856 shares ($159.0K)
Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$21.00
Current $4.76
Low $21.00
Median $21.00
High $21.00
1 analysts
$21.00
$21.00
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-6.20 ▼ -15.0% | $-6.20 — $-6.20 | 96% YoY | 1 |
| Next Q | $-5.96 ▼ -15.1% | $-5.96 — $-5.96 | 85% YoY | 1 |
| Current FY | $-24.13 ▼ -15.0% | $-24.13 — $-24.13 | 72% YoY | 1 |
| Next FY | $-21.46 ▼ -15.1% | $-21.46 — $-21.46 | 11% YoY | 1 |
Latest Reports
BULLISH
8-K
6/10
Aptevo announced positive clinical data from its RAINIER frontline AML trial, showing an 81% remission rate (CR/CRi) and
May 6, 2026
BULLISH
8-K
8/10
Aptevo Therapeutics announced positive interim clinical data for its drug candidate mipletamig in combination with venet
Mar 11, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $159.0K | NEW |
| FMR LLC | $66.00 | — |
| BANK OF AMERICA CORP | $66.00 | — |
3 institutional holders with $159.1K total value (16,870 shares) as of 2025-Q4. Top holders: VANGUARD, FMR, BANK. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 16,856 | $159.0K | 99.9% | NEW |
| 2 | FMR LLC | 7 | $66.00 | 0.0% | — |
| 3 | BANK OF AMERICA CORP /DE/ | 7 | $66.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | NEW | — | 16,856 | — | $159.0K | 2025-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$21.00 mean target
$21.00 Low
$21.00 High
| Metric | Value |
|---|---|
| Current Price | $4.76 |
| Target Low | $21.00 |
| Target Mean | $21.00 |
| Target Median | $21.00 |
| Target High | $21.00 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-6.20 | $-6.20 | $-6.20 | 95.9% | -15.0% | 0↑ 1↓ | $0.0B | 0.0% | 1 |
| Next Q 2026-09-30 |
$-5.96 | $-5.96 | $-5.96 | 85.2% | -15.1% | 0↑ 1↓ | $0.0B | 0.0% | 1 |
| Current FY 2026-12-31 |
$-24.13 | $-24.13 | $-24.13 | 72.4% | -15.0% | 0↑ 1↓ | $0.0B | 0.0% | 1 |
| Next FY 2027-12-31 |
$-21.46 | $-21.46 | $-21.46 | 11.1% | -15.1% | 0↑ 1↓ | $0.0B | 0.0% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-6.200 | |
| 7d ago | $-6.200 | |
| 30d ago | $-5.390 | -0.810 |
| 60d ago | $-5.390 | -0.810 |
| 90d ago | $0.000 | -6.200 |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jan 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 12, 2026
earnings_calendar
APVO Q1 2026 Earnings Scheduled — 2026-05-12
Mar 2, 2026
earnings_calendar
APVO Q4 2025 Earnings After Market Close — 2026-03-02